Featured Research

from universities, journals, and other organizations

'Molecular wipe': Potential treatment for 'pink eye' epidemic

Date:
September 29, 2011
Source:
American Chemical Society
Summary:
Scientists are reporting discovery of a potential new drug for epidemic keratoconjunctivitis (EKC) -- sometimes called "pink eye" -- a highly infectious eye disease that may occur in 15 million to 20 million people annually in the United States alone. Their report describes an innovative new "molecular wipe" that sweeps up viruses responsible for EKC.

Scientists are reporting discovery of a potential new drug for epidemic keratoconjunctivitis (EKC) -- sometimes called "pink eye" -- a highly infectious eye disease that may occur in 15 million to 20 million people annually in the United States alone.

Their report describing an innovative new "molecular wipe" that sweeps up viruses responsible for EKC appears in ACS's Journal of Medicinal Chemistry.

Ulf Ellervik and colleagues note that there is no approved treatment for EKC, which is caused by viruses from the same family responsible for the common cold. EKC affects the cornea, the clear, dome-shaped tissue that forms the outer layer of the eye. It causes redness, pain, tearing, and may reduce visions for months. "Patients are usually recommended to stay home from work or school, resulting in substantial economic losses," the scientists write.

They describe discovery of a potential new drug that sweeps up the viruses responsible for EKC, preventing the viruses from binding to and infecting the cornea. The drug removes viruses already in the eye and new viruses that are forming. In doing so, it would relieve symptoms, speed up healing (potentially avoiding impaired vision, and reduce and the risk of infecting the patient's other eye or spreading the infection within families, schools and work places, the scientists suggested.

The authors acknowledge funding from Adenovir Pharma AB, The Swedish Research Council, The Crafoord Foundation, and The Royal Physiographic Society in Lund.


Story Source:

The above story is based on materials provided by American Chemical Society. Note: Materials may be edited for content and length.


Journal Reference:

  1. Karolina Aplander, Marko Marttila, Sophie Manner, Niklas Arnberg, Olov Sterner, Ulf Ellervik. Molecular Wipes: Application to Epidemic Keratoconjuctivitis. Journal of Medicinal Chemistry, 2011; 110831132824018 DOI: 10.1021/jm200545m

Cite This Page:

American Chemical Society. "'Molecular wipe': Potential treatment for 'pink eye' epidemic." ScienceDaily. ScienceDaily, 29 September 2011. <www.sciencedaily.com/releases/2011/09/110928105903.htm>.
American Chemical Society. (2011, September 29). 'Molecular wipe': Potential treatment for 'pink eye' epidemic. ScienceDaily. Retrieved October 22, 2014 from www.sciencedaily.com/releases/2011/09/110928105903.htm
American Chemical Society. "'Molecular wipe': Potential treatment for 'pink eye' epidemic." ScienceDaily. www.sciencedaily.com/releases/2011/09/110928105903.htm (accessed October 22, 2014).

Share This



More Health & Medicine News

Wednesday, October 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins